series-a
Stage
About
Velomedix develops novel therapies to treat inflammatory diseases by targeting metabolic pathways. The company focuses on drug development for immune and inflammatory disorders.
Explore Velomedix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.